Manager × security

Green Alpha Advisors, LLC CRSP holdings history

Who else holds this security? →

CRISPR THERAPEUTICS AG · CUSIP H17182108 · CIK 1439207

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Green Alpha Advisors, LLC reported 55.80K CRSP (shares), valued at $3.04M, or 2.04% of its reported non-derivative portfolio. Filed 2026-08-11.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
2.04%
Shares
55.80K
55,804
Reported value
$3.04M
USD

Shares decreased 2.14%; reported value increased 12.20%, and weight changed -0.63 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20262.04%55,804SEC filing ↗Filed Aug 11, 2026
Q1 20262.67%57,022SEC filing ↗Filed Apr 7, 2026
Q4 20252.68%55,737SEC filing ↗Filed Jan 7, 2026
Q3 20253.44%55,012SEC filing ↗Filed Oct 15, 2025
Q2 20252.72%58,463SEC filing ↗Filed Aug 1, 2025
Q1 20252.08%57,361SEC filing ↗Filed Apr 9, 2025
Q4 20240.78%24,629SEC filing ↗Filed Jan 13, 2025
Q3 20240.71%19,158SEC filing ↗Filed Oct 7, 2024
Q2 20240.85%19,637SEC filing ↗Filed Aug 13, 2024
Q1 20241.33%26,956SEC filing ↗Filed Apr 10, 2024
Q4 20231.11%24,550SEC filing ↗Filed Jan 5, 2024
Q3 20231.22%34,880SEC filing ↗Filed Oct 10, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20231.22%34,880$1.58MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Oct 10, 2023
Q4 20231.11%24,550$1.54MShares decreased 29.62%; reported value decreased 2.93%, and weight changed -0.11 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 5, 2024
Q1 20241.33%26,956$1.84MShares increased 9.80%; reported value increased 19.55%, and weight changed +0.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 10, 2024
Q2 20240.85%19,637$1.06MShares decreased 27.15%; reported value decreased 42.27%, and weight changed -0.48 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2024
Q3 20240.71%19,158$900.04KShares decreased 2.44%; reported value decreased 15.14%, and weight changed -0.14 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 7, 2024
Q4 20240.78%24,629$969.40KShares increased 28.56%; reported value increased 7.71%, and weight changed +0.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 13, 2025
Q1 20252.08%57,361$1.95MShares increased 132.90%; reported value increased 101.36%, and weight changed +1.30 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 9, 2025
Q2 20252.72%58,463$2.84MShares increased 1.92%; reported value increased 45.68%, and weight changed +0.64 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 1, 2025
Q3 20253.44%55,012$3.57MShares decreased 5.90%; reported value increased 25.38%, and weight changed +0.72 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 15, 2025
Q4 20252.68%55,737$2.92MShares increased 1.32%; reported value decreased 18.02%, and weight changed -0.76 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 7, 2026
Q1 20262.67%57,022$2.71MShares increased 2.31%; reported value decreased 7.20%, and weight changed -0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 7, 2026
Q2 20262.04%55,804$3.04MShares decreased 2.14%; reported value increased 12.20%, and weight changed -0.63 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 11, 2026
Green Alpha Advisors, LLC · CRISPR THERAPEUTICS AG

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1439207","quarter":"2026Q2","cusip":"H17182108"}

get_institutional_manager_history
{"cik":"1439207","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.